{
  "abstract": "US officials have approved a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it.",
  "authors": [
    {
      "affiliations": [
        "Montreal"
      ],
      "name": "Owen Dyer"
    }
  ],
  "title": "Pill version of obesity jab is approved in US, with UK decision pending",
  "uid": "82a60f51-0f70-5a8f-850d-cb1447a6f180"
}